scholarly journals Single-dose amikacin plus 7 days of amoxicillin/clavulanate to treat acute cystitis caused by extended-spectrum beta-lactamase-producing Escherichia coli: A retrospective cohort study

2021 ◽  
Vol 62 (3) ◽  
pp. 310
Author(s):  
Sun Tae Ahn ◽  
Da Eun Han ◽  
Dong Hyun Lee ◽  
Jong Wook Kim ◽  
Hong Seok Park ◽  
...  
Author(s):  
Isabelle Vock ◽  
Lisandra Aguilar-Bultet ◽  
Adrian Egli ◽  
Pranita D Tamma ◽  
Sarah Tschudin-Sutter

Abstract We investigated relative proportions of extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) versus non-ESBL-PE (nESBL-PE) infections in ESBL-PE colonized patients. ESBL-PE are not causative for the majority of infections in hospitalized patients colonized with ESBL-PE. Site of infection and patient-level exposures may be useful predictors of nESBL-PE infections, potentially guiding empiric treatment recommendations.


2007 ◽  
Vol 52 (3) ◽  
pp. 1184-1186 ◽  
Author(s):  
David Sevillano ◽  
Lorenzo Aguilar ◽  
Luis Alou ◽  
María-José Giménez ◽  
Martha Torrico ◽  
...  

ABSTRACT Activity of simulated cefditoren urinary concentrations was determined against seven Escherichia coli isolates. Bactericidal activity was obtained from 4 to 24 h against TEM-1 (penicillinase production/hyperproduction), TEM-34 (IRT-6), and TEM-116 (extended-spectrum beta-lactamase [ESBL]) and from 6 to 8 h against SHV/TEM-116 (ESBL) but never against SHV/TEM-1 (ESBL). Extension of bactericidal activity depended on the resistance genotype/phenotype tested.


Sign in / Sign up

Export Citation Format

Share Document